The antiserum was produced against synthesized peptide derived from human Vinculin around the phosphorylation site of Tyr821. AA range:786-835

Phospho-Vinculin (Y821) Polyclonal Antibody detects endogenous levels of Vinculin protein only when phosphorylated at Y821.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):SGyRI

VCL

Vinculin

VCL ;
Vinculin ;
Metavinculin

Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions , where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function , resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene , but the biological validity of some variants has not been determined. [provided by RefSeq , Jul 2008] ,

Disease:Defects in VCL are the cause of cardiomyopathy dilated type 1W (CMD1W) [MIM:611407]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function , resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. ,Function:Involved in cell adhesion. May be involved in the attachment of the actin-based microfilaments to the plasma membrane. May also play important roles in cell morphology and locomotion. ,online information:Vinculin entry ,PTM:Aceylated; mainly by myristic acid but also small amount of palmitic acid. ,PTM:Phosphorylated; on serines , threonines and tyrosines. Phosphorylation on Tyr-1133 in activated platelets affects head-tail interactions and cell spreading but has no effect on actin binding nor on localization to focal adhesion plaques. ,similarity:Belongs to the vinculin/alpha-catenin family. ,subcellular location:Cytoplasmic face of adhesion plaques. ,subunit:Exhibits self-association properties. Interacts with NRAP and SORBS1 (By similarity) . Interacts with TLN1. Interacts with SYNM. ,tissue specificity:Metavinculin is muscle-specific. ,

Cell membrane ; Peripheral membrane protein ; Cytoplasmic side . Cell junction , adherens junction . Cell junction , focal adhesion . Cytoplasm , cytoskeleton . Cell membrane , sarcolemma ; Peripheral membrane protein ; Cytoplasmic side . Recruitment to cell-cell junctions occurs in a myosin II-dependent manner. Interaction with CTNNB1 is necessary for its localization to the cell-cell junctions. .

>>Focal adhesion ;
>>Adherens junction ;
>>Leukocyte transendothelial migration ;
>>Regulation of actin cytoskeleton ;
>>Bacterial invasion of epithelial cells ;
>>Shigellosis ;
>>Amoebiasis